» Articles » PMID: 23406386

Prevalence of Lymphedema in Women Undergoing Treatment for Breast Cancer in a Referral Center in Southeastern Brazil

Overview
Publisher Biomed Central
Date 2013 Feb 15
PMID 23406386
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.

Methods: We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.

Results: The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).

Conclusions: The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.

Citing Articles

Occurrence of axillary web syndrome without surgical intervention: a case report.

Alharazy S J Int Med Res. 2023; 51(1):3000605231152384.

PMID: 36694987 PMC: 9893068. DOI: 10.1177/03000605231152384.


The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer-10 Years after the ACOSOG Z0011 Trial First Publication.

Millen E, Cavalcante F, Zerwes F, Novita G, Souza A, Reis J Ann Surg Oncol. 2021; 29(2):1087-1095.

PMID: 34570334 DOI: 10.1245/s10434-021-10812-6.


The Level of Lymphedema Awareness among Women with Breast Cancer in the Kingdom of Saudi Arabia.

Alsharif F, Almutairi W, Shibily F, Alhothari F, Batwa F, Batwa N Int J Environ Res Public Health. 2021; 18(2).

PMID: 33450971 PMC: 7828393. DOI: 10.3390/ijerph18020627.


Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis.

Torgbenu E, Luckett T, Buhagiar M, Chang S, Phillips J BMC Cancer. 2020; 20(1):604.

PMID: 32600278 PMC: 7325022. DOI: 10.1186/s12885-020-07079-7.


Combined decongestive therapy and reduction of pain and heaviness in patients with breast cancer-related lymphedema.

Sheikhi Mobarakeh Z, Mokhtari-Hesari P, Lotfi-Tokaldany M, Montazeri A, Heidari M, Zekri F Support Care Cancer. 2019; 27(10):3805-3811.

PMID: 30729334 DOI: 10.1007/s00520-019-04681-9.


References
1.
Beurskens C, van Uden C, Strobbe L, Oostendorp R, Wobbes T . The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer. 2007; 7:166. PMC: 2031897. DOI: 10.1186/1471-2407-7-166. View

2.
Deo S, Ray S, Rath G, Shukla N, Kar M, Asthana S . Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer. 2004; 41(1):8-12. View

3.
Guerra M, Mendonca G, Teresa Bustamante-Teixeira M, Cintra J, Carvalho L, Magalhaes L . [Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil]. Cad Saude Publica. 2009; 25(11):2455-66. DOI: 10.1590/s0102-311x2009001100015. View

4.
Yen T, Fan X, Sparapani R, Laud P, Walker A, Nattinger A . A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol. 2009; 16(4):979-88. PMC: 2729500. DOI: 10.1245/s10434-009-0347-2. View

5.
Hojris I, Andersen J, Overgaard M, Overgaard J . Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol. 2000; 39(3):355-72. DOI: 10.1080/028418600750013131. View